These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7744263)

  • 1. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV.
    Duesberg PH
    Genetica; 1995; 95(1-3):51-70. PubMed ID: 7744263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D
    Genetica; 1995; 95(1-3):25-50. PubMed ID: 7538088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AIDS dilemma: drug diseases blamed on a passenger virus.
    Duesberg P; Rasnick D
    Genetica; 1998; 104(2):85-132. PubMed ID: 10220905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--impact on the immune and other systems.
    Poon MC
    Ann Hematol; 1994; 68 Suppl 3():S83-6. PubMed ID: 7910044
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS acquired by drug consumption and other noncontagious risk factors.
    Duesberg PH
    Pharmacol Ther; 1992; 55(3):201-77. PubMed ID: 1492119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development.
    Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B
    AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the source of infection for HIV-infected hemophiliacs in the U.K. from 1979 to 1984.
    Jewell NP
    Stat Med; 2009 May; 28(10):1464-72. PubMed ID: 19235711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion and cytomegalovirus-associated AIDS-defining disease in hemophiliacs. Hemophilia Malignancy Study.
    Ragni MV; Triulzi DJ; Bass D; Duerstein S
    Transfusion; 1996 Aug; 36(8):681-4. PubMed ID: 8780661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
    Goldsmith JM; Deutsche J; Tang M; Green D
    Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?
    Eichinger S; Pabinger I; Kyrle PA; Köller U; Kier P; Schneider B; Lechner K
    Haemostasis; 1992; 22(1):25-31. PubMed ID: 1521824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human immunodeficiency virus (HIV) infection among hemophiliacs in Fukuoka, Japan.
    Kashiwagi S; Hayashi J; Ikematsu H; Noguchi A; Ikeda K; Kishida K; Shirakawa M; Takenaka A; Mori R
    Microbiol Immunol; 1988; 32(8):851-5. PubMed ID: 3143898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus.
    Tsuchie H; Kawatani T; Nakayama E; Matsui T; Kurimura T; Hinuma Y
    Microbiol Immunol; 1985; 29(11):1083-7. PubMed ID: 2869397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
    Seremetis SV
    Semin Hematol; 1993 Oct; 30(4 Suppl 5):10-3. PubMed ID: 7903480
    [No Abstract]   [Full Text] [Related]  

  • 15. Infection of hemophiliacs with HIV.
    Aronson DL
    J Clin Apher; 1993; 8(2):117-9. PubMed ID: 8226704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate.
    Di Paolantonio T; Mariani G; Ghirardini A; Gringeri A; Mannucci PM; Mastrullo L; De Biasi R; Giustarini G; Morfini M; Schiavoni M
    J Med Virol; 1992 Feb; 36(2):71-4. PubMed ID: 1583469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1.
    Jackson JB; Erice A; Englund JA; Edson JR; Balfour HH
    Transfusion; 1988; 28(2):187-9. PubMed ID: 2895517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulins in the treatment of adolescent and adult HIV-infected hemophiliacs.
    Wintergerst U; Niinivaara-Kreuzer K; Notheis G; Auberger K; Brückmann C; Gandenberger S; Belohradsky BH
    Clin Investig; 1994 Jan; 72(2):122-6. PubMed ID: 8186657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of factor VIII concentrates on the immune system of patients with hemophilia.
    Mannucci PM
    Thromb Haemost; 1995 Jul; 74(1):437-9. PubMed ID: 8578501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemophilia and acquired immunodeficiency].
    Allain JP
    Rev Prat; 1989 Dec; 39(30):2674-7. PubMed ID: 2515581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.